Perspective Therapeutics (CATX) Research & Development (2010 - 2026)
Perspective Therapeutics recorded quarterly Research & Development of $21.4 million in Q1 2026, down 35.09% quarter-over-quarter from $32.9 million in Q4 2025, and up 49.12% year-over-year from $14.3 million in Q1 2025.
Perspective Therapeutics' Research & Development history runs 17 years deep, the most recent figure standing at $21.4 million for Q1 2026.
- In Q1 2026, Research & Development rose 49.12% year-over-year to $21.4 million; the TTM figure through Mar 2026 stood at $91.3 million (up 88.08% YoY), while the FY2025 annual figure was $84.2 million, up 102.26% from the prior year.
- Research & Development came in at $21.4 million for Q1 2026 at Perspective Therapeutics, down from $32.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $32.9 million in Q4 2025 to a low of $468000.0 in Q4 2022.
- A 5-year average of $10.1 million and a median of $7.5 million in 2024 frame the typical range for Research & Development.
- Across the five-year window, Research & Development retreated 12.52% in 2022 and surged 1412.82% in 2023, its largest moves.
- Perspective Therapeutics' Research & Development stood at $468000.0 in 2022, then soared by 1412.82% to $7.1 million in 2023, then jumped by 81.96% to $12.9 million in 2024, then soared by 155.56% to $32.9 million in 2025, then slumped by 35.09% to $21.4 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $21.4 million, $32.9 million, and $20.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 21.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.37 Mn |
| Dec 31, 2025 | 32.92 Mn |
| Sep 30, 2025 | 20.34 Mn |
| Jun 30, 2025 | 16.62 Mn |
| Mar 31, 2025 | 14.33 Mn |
| Dec 31, 2024 | 12.88 Mn |
| Sep 30, 2024 | 12.03 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Mar 31, 2024 | 7.45 Mn |
| Dec 31, 2023 | 7.08 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 5.37 Mn |
| Mar 31, 2023 | 3.31 Mn |
| Dec 31, 2022 | 468,000.00 |
| Sep 30, 2022 | 708,000.00 |
| Jun 30, 2022 | 796,000.00 |
| Mar 31, 2022 | 549,000.00 |
| Dec 31, 2021 | 535,000.00 |
| Sep 30, 2021 | 702,000.00 |
| Mar 31, 2021 | 362,000.00 |
| Dec 31, 2020 | 285,000.00 |
| Sep 30, 2020 | 312,000.00 |
| Jun 30, 2020 | 322,000.00 |
| Mar 31, 2020 | 294,000.00 |
| Dec 31, 2019 | 277,000.00 |
| Sep 30, 2019 | 233,000.00 |
| Jun 30, 2019 | 341,000.00 |
| Mar 31, 2019 | 299,000.00 |
| Dec 31, 2018 | 414,000.00 |
| Sep 30, 2018 | 420,000.00 |
| Jun 30, 2018 | 572,000.00 |
| Mar 31, 2018 | 473,000.00 |
| Dec 31, 2017 | 340,000.00 |
| Sep 30, 2017 | 362,000.00 |
| Jun 30, 2017 | 65,000.00 |
| Mar 31, 2017 | 327,000.00 |
| Dec 31, 2016 | 150,000.00 |
| Sep 30, 2016 | 172,000.00 |
| Jun 30, 2016 | 143,000.00 |
| Mar 31, 2016 | 183,000.00 |
| Dec 31, 2015 | 58,000.00 |
| Sep 30, 2015 | 144,000.00 |
| Jun 30, 2015 | 156,364.00 |
| Mar 31, 2015 | 141,399.00 |
| Dec 31, 2014 | 140,627.00 |
| Sep 30, 2014 | 176,610.00 |
| Jun 30, 2014 | 198,172.00 |
| Mar 31, 2014 | 153,611.00 |
| Dec 31, 2013 | 170,030.00 |
| Sep 30, 2013 | 146,990.00 |
| Jun 30, 2013 | 181,322.00 |
| Mar 31, 2013 | 155,137.00 |
| Dec 31, 2012 | 149,176.00 |
| Sep 30, 2012 | 141,472.00 |
| Jun 30, 2012 | 207,367.00 |
| Mar 31, 2012 | 132,237.00 |
| Dec 31, 2011 | 189,661.00 |
| Sep 30, 2011 | 251,314.00 |
| Jun 30, 2011 | 606,869.00 |
| Mar 31, 2011 | 244,184.00 |
| Dec 31, 2010 | 15,612.00 |
| Sep 30, 2010 | 114,522.00 |